Venofer and Linagliptin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Venofer (iron sucrose) and Linagliptin (linagliptin). Common drug interactions include cerebrovascular accident among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Venofer and Linagliptin. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Venofer?

Venofer has active ingredients of iron sucrose. It is often used in anemia. eHealthMe is studying from 8,895 Venofer users. Check the latest studies of Venofer.

What is Linagliptin?

Linagliptin has active ingredients of linagliptin. eHealthMe is studying from 8,112 Linagliptin users. Check the latest studies of Linagliptin.



On Jul, 30, 2026

31 people who take Venofer and Linagliptin together, and have interactions are studied.

Venofer and Linagliptin drug interactions.

What are the common drug interactions of Venofer and Linagliptin, by gender? *:

female:

  1. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  2. Acute myocardial infarction (acute heart attack)
  3. Chest pain
  4. Infusion site pain
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Blood pressure increased
  7. Cold sweat
  8. Dizziness
  9. Oesophagitis (inflammation of oesophagus)
  10. Starvation (a severe deficiency in caloric energy, nutrient, and vitamin intake)

male:

  1. Anaemia (lack of blood)
  2. Cellulitis (infection under the skin)
  3. Blood glucose increased
  4. Blood pressure diastolic decreased
  5. Blood pressure fluctuation
  6. Blood pressure systolic increased
  7. Body temperature increased
  8. Diarrhoea
  9. Drug ineffective
  10. Faeces discoloured

What are the common drug interactions of Venofer and Linagliptin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  2. Anaemia (lack of blood)
  3. Infusion site pain
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Abdominal pain upper
  6. Appendicitis perforated (perforated appendicitis is a condition in which an inflamed appendix bursts)
  7. Asthenia (weakness)
  8. Blood glucose increased
  9. Blood pressure diastolic decreased
  10. Blood pressure fluctuation

What are the existing conditions these people have? *

  1. Anaemia (lack of blood): 19 people, 61.29%
  2. Type 2 Diabetes: 2 people, 6.45%
  3. High Blood Pressure: 2 people, 6.45%
  4. Haematochezia (passage of stools containing blood): 2 people, 6.45%
  5. Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 2 people, 6.45%
  6. Gastrointestinal Angiodysplasia (a small vascular malformation of the gut): 2 people, 6.45%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 6.45%
  8. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 6.45%
  9. Chronic Kidney Disease: 2 people, 6.45%
  10. Cardiac Failure: 2 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Venofer and Linagliptin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Venofer and Linagliptin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Venofer:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Linagliptin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Venofer and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Linagliptin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on iron sucrose and linagliptin (the active ingredients of Venofer and Linagliptin, respectively), and Venofer and Linagliptin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: